Detalles de la búsqueda
1.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Haematologica
; 108(9): 2467-2475, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951150
2.
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Ann Hematol
; 102(9): 2459-2469, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306711
3.
Assessment of the expression and response of PD-1, LAG-3, and TIM-3 after neoadjuvant radiotherapy in rectal cancer.
Neoplasma
; 68(4): 742-750, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33847134
4.
High Biologically Effective Dose Radiotherapy for Brain Metastases May Improve Survival and Decrease Risk for Local Relapse Among Patients With Small-Cell Lung Cancer: A Propensity-Matching Analysis.
Cancer Control
; 27(2): 1073274820936287, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614270
5.
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
Am J Hematol
; 95(9): 1047-1056, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449800
6.
Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study.
Blood
; 126(12): 1424-32; quiz 1517, 2015 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26109206
7.
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.
Cancer Rep (Hoboken)
; 6(5): e1800, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919649
8.
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
EJHaem
; 4(1): 78-89, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819187
9.
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.
Leukemia
; 35(6): 1671-1682, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32943751
10.
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Leukemia
; 35(1): 130-142, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152465
11.
Patterns of supraclavicular area failure after mastectomy in breast cancer patients: implications for target volume delineation.
J Int Med Res
; 48(9): 300060520953315, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32938273
12.
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG.
Blood Adv
; 4(13): 3141-3153, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32658985
13.
Role of postoperative radiotherapy in pT3N0 rectal cancer: A risk-stratification system based on population analyses.
Cancer Med
; 8(3): 1024-1033, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30714683
14.
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG).
Aging (Albany NY)
; 11(19): 8463-8473, 2019 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31586991
15.
Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG).
Leuk Lymphoma
; 60(11): 2669-2678, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31060406
16.
Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.
JAMA Netw Open
; 2(3): e190194, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30821826
17.
Prognostic value of vascular endothelial growth factor receptor 1 and class III ß-tubulin in survival for non-metastatic rectal cancer.
World J Gastrointest Oncol
; 10(10): 351-359, 2018 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30364886
18.
Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α.
Onco Targets Ther
; 11: 8507-8515, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30555241
19.
Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
Radiat Oncol
; 13(1): 171, 2018 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30201005
20.
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.
Blood Adv
; 2(18): 2369-2377, 2018 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30242098